Meg Osler

Summary

Publications

  1. doi request reprint Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study
    Meg Osler
    Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    HIV Med 11:121-9. 2010
  2. doi request reprint Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa
    Andrew Boulle
    School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Cape Town, South Africa
    AIDS 24:563-72. 2010
  3. doi request reprint Provision of antiretroviral therapy to children within the public sector of South Africa
    Peter Bock
    School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa
    Trans R Soc Trop Med Hyg 102:905-11. 2008
  4. pmc Reduced referral and case fatality rates for severe symptomatic hyperlactataemia in a South African public sector antiretroviral programme: a retrospective observational study
    Charlotte Schutz
    Infectious Diseases Unit, GF Jooste Hospital, Duinefontein Road, Manenberg, 7764, Cape Town, South Africa
    AIDS Res Ther 7:13. 2010
  5. ncbi request reprint Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa
    David Stead
    GF Jooste Hospital, Cape Town, South Africa
    Antivir Ther 13:937-43. 2008

Detail Information

Publications5

  1. doi request reprint Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study
    Meg Osler
    Infectious Disease Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
    HIV Med 11:121-9. 2010
    ..Symptomatic hyperlactataemia and lactic acidosis (SHLA) are potentially life-threatening complications associated with stavudine (d4T), an antiretroviral therapy (ART) drug widely used in developing countries...
  2. doi request reprint Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa
    Andrew Boulle
    School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Cape Town, South Africa
    AIDS 24:563-72. 2010
    ..We report on outcomes after 7 years of a community-based antiretroviral therapy (ART) programme in Khayelitsha, South Africa, with death registry linkages to correct for mortality under-ascertainment...
  3. doi request reprint Provision of antiretroviral therapy to children within the public sector of South Africa
    Peter Bock
    School of Public Health and Family Medicine, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa
    Trans R Soc Trop Med Hyg 102:905-11. 2008
    ..The higher death rates at level 2 & 3 facilities are most likely due to recruitment of sicker patients at this level...
  4. pmc Reduced referral and case fatality rates for severe symptomatic hyperlactataemia in a South African public sector antiretroviral programme: a retrospective observational study
    Charlotte Schutz
    Infectious Diseases Unit, GF Jooste Hospital, Duinefontein Road, Manenberg, 7764, Cape Town, South Africa
    AIDS Res Ther 7:13. 2010
    ..This study assessed trends in referral rate, severity at presentation and case fatality rate for severe SHL...
  5. ncbi request reprint Severe hyperlactataemia complicating stavudine first-line antiretroviral therapy in South Africa
    David Stead
    GF Jooste Hospital, Cape Town, South Africa
    Antivir Ther 13:937-43. 2008
    ..In the public sector antiretroviral therapy (ART) programme in South Africa the standardized first-line regimen includes stavudine (d4T). Severe symptomatic hyperlactataemia (SHL) is a potentially life-threatening complication of d4T...